Novel defect in phosphatidylinositol 4-kinase type 2-alpha (PI4K2A) at the membrane-enzyme interface is associated with metabolic cutis laxa.


Journal

Journal of inherited metabolic disease
ISSN: 1573-2665
Titre abrégé: J Inherit Metab Dis
Pays: United States
ID NLM: 7910918

Informations de publication

Date de publication:
11 2020
Historique:
received: 30 12 2019
revised: 11 05 2020
accepted: 13 05 2020
pubmed: 18 5 2020
medline: 8 10 2021
entrez: 18 5 2020
Statut: ppublish

Résumé

Inherited cutis laxa, or inelastic, sagging skin is a genetic condition of premature and generalised connective tissue ageing, affecting various elastic components of the extracellular matrix. Several cutis laxa syndromes are inborn errors of metabolism and lead to severe neurological symptoms. In a patient with cutis laxa, a choreoathetoid movement disorder, dysmorphic features and intellectual disability we performed exome sequencing to elucidate the underlying genetic defect. We identified the amino acid substitution R275W in phosphatidylinositol 4-kinase type IIα, caused by a homozygous missense mutation in the PI4K2A gene. We used lipidomics, complexome profiling and functional studies to measure phosphatidylinositol 4-phosphate synthesis in the patient and evaluated PI4K2A deficient mice to define a novel metabolic disorder. The R275W residue, located on the surface of the protein, is involved in forming electrostatic interactions with the membrane. The catalytic activity of PI4K2A in patient fibroblasts was severely reduced and lipid mass spectrometry showed that particular acyl-chain pools of PI4P and PI(4,5)P

Identifiants

pubmed: 32418222
doi: 10.1002/jimd.12255
pmc: PMC7687218
doi:

Substances chimiques

Minor Histocompatibility Antigens 0
Phosphatidylinositols 0
Phosphotransferases (Alcohol Group Acceptor) EC 2.7.1.-
phosphatidylinositol phosphate 4-kinase EC 2.7.1.67

Types de publication

Case Reports Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1382-1391

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL090648
Pays : United States

Informations de copyright

© 2020 The Authors. Journal of Inherited Metabolic Disease published by John Wiley & Sons Ltd on behalf of SSIEM.

Références

Nature. 2016 Jan 21;529(7586):408-12
pubmed: 26760201
EMBO Rep. 2014 Oct;15(10):1085-92
pubmed: 25168678
Mol Biol Cell. 2008 Feb;19(2):711-21
pubmed: 18077555
Cell Rep. 2015 Jan 6;10(1):8-19
pubmed: 25543136
Nat Methods. 2011 Mar;8(3):267-72
pubmed: 21278744
Mol Neurobiol. 2016 Jan;53(1):621-630
pubmed: 25502460
Mol Biol Cell. 2010 Dec;21(23):4141-50
pubmed: 20881054
Proc Natl Acad Sci U S A. 2009 Jul 14;106(28):11535-9
pubmed: 19581584
Ann Clin Transl Neurol. 2018 Oct 24;5(12):1617-1621
pubmed: 30564627
Hum Mol Genet. 2015 Jul 1;24(13):3732-41
pubmed: 25855803
Nat Cell Biol. 2016 Jan;18(1):132-8
pubmed: 26571211
J Biol Chem. 2015 Nov 13;290(46):27460-72
pubmed: 26324718
Mol Biol Cell. 2014 Apr;25(8):1251-62
pubmed: 24523285
J Cancer. 2014 Oct 28;5(9):790-6
pubmed: 25368680
Nat Commun. 2014 Mar 28;5:3552
pubmed: 24675427
Cell Metab. 2012 Oct 3;16(4):538-49
pubmed: 22982022
Eur J Biochem. 1990 Aug 17;191(3):669-77
pubmed: 2143986
Biochim Biophys Acta. 2015 Aug;1851(8):1066-82
pubmed: 25680866
J Biol Chem. 2015 Apr 10;290(15):9919-28
pubmed: 25713145
Trends Cell Biol. 2006 Jul;16(7):351-61
pubmed: 16793271
Prog Lipid Res. 2013 Jul;52(3):294-304
pubmed: 23608234
J Inherit Metab Dis. 2020 Nov;43(6):1382-1391
pubmed: 32418222
Bioessays. 2015 Mar;37(3):267-77
pubmed: 25404370
PLoS Pathog. 2014 Jul 03;10(7):e1004222
pubmed: 24992562
J Inherit Metab Dis. 2014 Jul;37(4):643-8
pubmed: 24894157
Physiol Rev. 2013 Jul;93(3):1019-137
pubmed: 23899561
J Cell Sci. 2006 Feb 1;119(Pt 3):571-81
pubmed: 16443754
Proc Natl Acad Sci U S A. 2015 Jun 2;112(22):7015-20
pubmed: 26038556
Neurology. 2014 Nov 25;83(22):2054-61
pubmed: 25355836
Eur J Biochem. 1987 Apr 1;164(1):171-9
pubmed: 3549301
Bioessays. 2014 Jan;36(1):52-64
pubmed: 24323921
Mol Neurobiol. 2013 Feb;47(1):361-72
pubmed: 23054682
Biochim Biophys Acta. 2009 Sep;1792(9):903-14
pubmed: 19171192
EMBO Rep. 2012 Dec;13(12):1087-94
pubmed: 23146885
Oncogene. 2010 Apr 29;29(17):2550-9
pubmed: 20154717
Anal Biochem. 1986 May 1;154(2):655-63
pubmed: 3728974
Nat Chem Biol. 2010 Dec;6(12):907-13
pubmed: 21079602
Biochem J. 2010 May 27;428(3):375-84
pubmed: 20370717
Eur J Hum Genet. 2016 Oct;24(10):1460-6
pubmed: 27165006
Mol Biol Cell. 2016 Mar 15;27(6):990-1001
pubmed: 26823017

Auteurs

Miski Mohamed (M)

Department of Paediatrics, Radboud University Medical Center, Nijmegen, The Netherlands.

Thatjana Gardeitchik (T)

Department of Paediatrics, Radboud University Medical Center, Nijmegen, The Netherlands.
Department of Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.

Shanti Balasubramaniam (S)

Clinical Genetic Department, Hospital Kuala Lumpur, Jalan Pahang, Kuala Lumpur, Malaysia.
Discipline of Genetic Medicine, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.
Western Sydney Genetics Program, The Children's Hospital at Westmead, Sydney, New South Wales, Australia.

Sergio Guerrero-Castillo (S)

Radboud Center for Mitochondrial Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
Translational Metabolic Laboratory, Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.

Daisy Dalloyaux (D)

Department of Paediatrics, Radboud University Medical Center, Nijmegen, The Netherlands.

Sanne van Kraaij (S)

Translational Metabolic Laboratory, Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.

Hanka Venselaar (H)

Center of Molecular and Biomolecular Informatics, Radboud University Medical Center, Nijmegen, The Netherlands.

Alexander Hoischen (A)

Department of Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.

Zsolt Urban (Z)

Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Ulrich Brandt (U)

Radboud Center for Mitochondrial Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
Translational Metabolic Laboratory, Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.

Raya Al-Shawi (R)

Wolfson Drug Discovery Unit, Division of Medicine, Royal Free Campus, University College London, London, UK.

J Paul Simons (JP)

Wolfson Drug Discovery Unit, Division of Medicine, Royal Free Campus, University College London, London, UK.

Michele Frison (M)

Wolfson Drug Discovery Unit, Division of Medicine, Royal Free Campus, University College London, London, UK.

Lock-Hock Ngu (LH)

Clinical Genetic Department, Hospital Kuala Lumpur, Jalan Pahang, Kuala Lumpur, Malaysia.

Bert Callewaert (B)

Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium.

Hans Spelbrink (H)

Department of Paediatrics, Radboud University Medical Center, Nijmegen, The Netherlands.

Wouter W Kallemeijn (WW)

Department of Medical Biochemistry, Leiden Institute of Chemistry, Leiden University, Leiden, The Netherlands.
Department of Chemistry, Imperial College London, London, UK.

Johannes M F G Aerts (JMFG)

Department of Medical Biochemistry, Leiden Institute of Chemistry, Leiden University, Leiden, The Netherlands.

Mark G Waugh (MG)

Lipid and Membrane Biology Group, Institute for Liver & Digestive Health, University College London, London, UK.

Eva Morava (E)

Haywards Genetics Center, Tulane University, New Orleans, Louisiana, USA.
Department of Pediatrics, University Medical Centre, Leuven, Belgium.

Ron A Wevers (RA)

Translational Metabolic Laboratory, Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH